Aligos Therapeutics, Inc.ALGSNASDAQ
LOADING
|||
Cash Flow Performance
Trending lower, below historical average, strong compound growth.
Left:
||||
Free cash flow yield
Latest
-32.40%
↓ 269% below average
Average (6y)
-8.78%
Historical baseline
Range
High:-0.11%
Low:-32.40%
CAGR
+158.4%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | -32.40% | -69.3% |
| 2023 | -19.14% | -142.3% |
| 2022 | -7.90% | -701.5% |
| 2021 | -0.99% | -205.0% |
| 2020 | -0.32% | +46.9% |
| 2019 | -0.61% | -458.5% |
| 2018 | -0.11% | - |